Skip to main content

Table 2 Top 5 NCDs by demographic, military characteristics and childhood adversity

From: Hospital admissions for non-communicable disease in the UK military and associations with alcohol use and mental health: a data linkage study

  Full sample characteristics (n = 8602) Gastrointestinal Disorders (n = 303) Other Joint Disorders (n = 291) Arthritis/Osteoarthritis (n = 131) Hypertension (n = 105) Prostate and other genitourinary diseases (n = 90)
Age in years at phase 2 (Mean (S.D.)) (n = 8602) 36.02 (9.20) 38.85 (9.42)*** 35.70 (9.00) 41.29 (8.61)*** 44.63 (9.41)*** 38.30 (9.34)
  n (weighted proportion, 95% CIs) n (weighted proportion with condition, 95% CIs) n (weighted proportion with condition, 95% CIs) n (weighted proportion with condition, 95% CIs) n (weighted proportion with condition, 95% CIs) n (weighted proportion with condition, 95% CIs)
Sex (n = 8602)
 Male 7661 (90.49; 89.8–91.1) 267 (3.65; 3.15–4.16) 269 (3.50; 3.02–3.99) 118 (1.55; 1.23–1.88) (*) 90 (1.26; 0.96–1.56)
 Female 941 (9.50; 8.80–10.1) 36 (3.51; 2.11–4.91) 22 (2.12; 1.03–3.22) 13 (1.35; 0.46–2.25) (*) 0
Relationship status at phase 2 (n = 8575)
 In a relationship 6602 (79.07; 78.06–80.05) 244 (3.80; 3.29–4.39) 228 (3.42; 2.95–3.98) 112 (1.66; 1.34–2.06) 86 (1.49; 1.18–1.88) 77 (1.24; 0.96–1.60)
 Not in a relationship 1973 (20.92; 19.95–21.94) 59 (3.10; 2.26–4.23) 63 (3.24; 2.41–4.33) 19 (1.11; 0.66–1.87) 19 (1.02; 0.59–1.76) 13 (0.78; 0.41–1.49)
Rank at phase 2 (n = 8602)
 Officer 1930 (20.03; 19.08–20.98) 86 (4.26; 3.21–5.32) 60 (2.99; 2.11–3.87) 38 (1.76; 1.11–2.41) 26 (1.57; 0.90–2.23) 20 (0.95; 0.45–1.45)
 NCO and other ranks 6672 (79.96; 79.01–80.91) 217 (3.48; 2.95–4.02) 231 (3.47; 2.95–3.99) 93 (1.48; 1.13–1.8) 79 (1.33; 1.00–1.67) 70 (1.18; 0.87–1.50)
Left service marker (n = 8588)
 Serving 6471 (71.34; 70.18–72.50) 208 (3.17; 2.65–3.68) 236 (3.63; 3.09–4.17) 93 (1.43; 1.08–1.77) 57 (0.94; 0.66–1.22) 62 (1.04; 0.73–1.34)
 Discharged 2117 (28.65; 27.49–29.81) 95 (4.84; 3.77–5.91) ** 55 (2.74; 1.92–3.57) 38 (1.81; 1.16–2.45) 48 (2.50; 1.72–3.27)*** 28 (1.38; 0.81–1.96)
Regular/Reserve status (n = 8602)
 Regular 7059 (88.72; 88.07–89.38) 225 (3.46; 2.95–3.97) 235 (3.36; 2.87–3.85) 105 (1.52; 1.19–1.85) 77 (1.2; 0.95–1.58) 76 (1.14; 0.85–1.44)
 Reserve 1543 (11.27; 10.61–11.92) 78 (5.07; 3.75–6.39)* 56 (3.47; 2.40–4.55) 26 (1.67; 0.91–2.44) 28 (2.29; 1.34–3.24)* 14 (1.10; 0.44–1.76)
Service (n = 8602)
 Naval Services 1317 (16.38; 15.45–17.31) 32 (2.87; 1.78–3.97) 47 (3.70; 2.52–4.89) 25 (1.79; 0.97–2.61) 18 (1.53; 0.76–2.31) 10 (0.73; 0.2–1.2)
 Army 5628 (64.16; 62.9–65.36) 228 (4.20; 3.56–4.8) 207 (3.66; 3.08–4.24) 85 (1.51; 1.13–1.88) 65 (1.30; 0.94–1.66) 69 (1.35; 0.9–1.71)
 RAF 1657 (19.44; 18.45–20.43) 43 (2.46; 1.60–3.33)** 37 (2.15; 1.34–2.97)** 21 (1.40; 0.72–2.09) 22 (1.50; 0.79–2.22) 11 (0.79; 0.24–1.3)
Deployed to Iraq or Afghanistan before phase 2 (n = 8602)
 No deployment 2809 (43.55; 42.30–44.81) 118 (4.35; 3.52–5.19) 84 (3.00; 2.30–3.70) (*) 49 (1.95; 1.39–2.52) 32 (1.27; 0.81–1.74)
 Iraq only 3696 (37.19; 36.0–38.37) 127 (3.29; 2.59–3.99) 133 (3.53; 2.82–4.24) (*) 37 (0.93; 0.56–1.30)** 33 (0.91; 0.54–1.29)
 Afghanistan only 917 (8.821; 8.153–9.489) 27 (2.83; 1.50–4.16) 27 (3.29; 1.8–4.76) (*) 8 (1.21; 0.26–2.15) 11 (1.04; 0.27–1.80)
Iraq and Afghanistan 1180 (10.42; 9.733–11.11) 31 (2.64; 1.49–3.79) 47 (4.41; 2.94–5.87)* (*) 11 (0.76; 0.22–1.29)* 14 (1.46; 0.53–2.38)
Role in parent unit at phase 2 (n = 8512)
 Combat 2035 (24.01; 22.94–25.08) 52 (2.79; 1.91–3.68) 78 (3.76; 2.79–4.73) 27 (1.40; 0.78–2.01) 19 (1.05; 0.51–1.58) 16 (0.81; 0.34–1.28)
 Combat support 1011 (11.41; 10.63–12.19) 38 (4.25; 2.69–5.81) 34 (3.20; 1.93–4.48) 12 (1.20; 0.39–2.01) 10 (1.32; 0.43–2.20) 12 (1.33; 0.48–2.10)
 Combat service support 5466 (64.57; 63.37–65.76) 209 (3.84; 3.23–4.44) 178 (3.30; 2.74–3.86) 91 (1.64; 1.25–2.03) 75 (1.53; 1.13–1.92) 62 (1.24; 0.88–1.60)
Family relationship adversities in childhood (n = 8510)
 0/1 5479 (64.22; 63.00–65.41) 195 (3.67; 3.11–4.31) 179 (3.26; 2.78–3.86) 88 (1.64; 1.29–2.09) 56 (1.15; 0.86–1.54) 55 (1.06; 0.78–1.44)
 2/3 1720 (19.94; 18.96–20.96) 53 (3.10; 2.23–4.23) 60 (3.28; 2.41–4.45) 22 (1.14; 0.68–1.90) 24 (1.58; 0.99–2.51) 13 (0.83; 0.46–1.52)
 4+ 1311 (15.84; 14.94–16.79) 52 (4.30; 3.12–5.90) 52 (4.14; 3.02–5.65) 21 (1.71; 1.03–2.82) 25 (2.18; 1.40–3.37)* 22 (1.93; 1.19–3.09)*
Number of NCDs (median, IQR) (n = 8602) 0 (0–0) 1 (1–2) 1 (1–2) 2 (2–3) 1 (1–3) 2 (2–4)
  1. Statistically significant association with the NCD outcome in unadjusted Cox regression analysis (restricted to events occurring after phase 2) at *p < 0.05, **p < 0.01, ***p < 0.001
  2. (*) – Numbers and percentages are not reported when n is smaller than 8 due to Hospital Episode Statistics reporting guidelines
\